<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03972956</url>
  </required_header>
  <id_info>
    <org_study_id>SAMPGICUS</org_study_id>
    <nct_id>NCT03972956</nct_id>
  </id_info>
  <brief_title>Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease</brief_title>
  <official_title>Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Renmin Hospital of Wuhan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Renmin Hospital of Wuhan University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study are to collect and store samples including blood, normal and tumor
      tissue from patients with colorectal cancer or gastric cancer, to collect and store samples
      including blood and/or normal gastrointestinal tissue (if available) from patients with
      non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD),
      gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and
      allow access to relevant clinical information for current and future protocols.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Confirmation of diagnosis by pathologist</measure>
    <time_frame>Up to 3 years</time_frame>
    <description>Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Gastric Cancer</condition>
  <condition>Inflammatory Bowel Diseases</condition>
  <condition>Gastric Ulcer</condition>
  <condition>Hemorrhoids</condition>
  <condition>Hernia</condition>
  <arm_group>
    <arm_group_label>Colorectal cancer or gastric cancer patient</arm_group_label>
    <description>Patients suffering from CRC or gastric cancer scheduled to have surgical resection of colon/rectum or stomach.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-malignant disease patient</arm_group_label>
    <description>Patients suffering from non-malignant disease scheduled to have surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention will be given to patients.</intervention_name>
    <description>Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.</description>
    <arm_group_label>Colorectal cancer or gastric cancer patient</arm_group_label>
    <arm_group_label>Non-malignant disease patient</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biospecimens will be analyzed to study, but not limited to, genomics, epigenomics, and
      proteomics.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants who are planning to undergo surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease
             that requires undergoing surgery.

          -  Must be willing and able to provide informed consent.

        Exclusion Criteria:

          -  Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Tao Fu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renmin Hospital of Wuhan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tao Fu, MD</last_name>
    <phone>+8613720120190</phone>
    <email>tfu001@whu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2019</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Renmin Hospital of Wuhan University</investigator_affiliation>
    <investigator_full_name>Tao Fu</investigator_full_name>
    <investigator_title>Director of Department of GI Surgery II</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
    <mesh_term>Hemorrhoids</mesh_term>
    <mesh_term>Stomach Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

